Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 28 Sep 2021
Fully human anti-TNF alfa monoclonal antibody Humira obtains additional approval for high dose regimen of ulcerative colitis in adult patients and for new regimen in paediatric patients
27 September 2021 - Eisai and EA Pharma announced today the additional approval for a high dose regimen in adult ...
Posted by Michael Wonder on 28 Sep 2021
VFMCRP announces approval for Tavneos (avacopan) for the treatment of ANCA associated vasculitis in Japan
27 September 2021 - Partner Kissei to market Tavneos in Japan, with launch expected as soon as possible following National Health ...
Posted by Michael Wonder on 28 Sep 2021
European Medicines Agency grants Atara Biotherapeutics accelerated assessment of tab-cel for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease
27 September 2021 - Atara on track to submit MAA in November 2021. ...
Posted by Michael Wonder on 27 Sep 2021
The doctors betraying their oath to do no harm
25 September 2021 - Medical procedures that don’t help the patient, overdiagnosis, the ‘medicalisation of normal’… two doctors lift the lid. ...
Posted by Michael Wonder on 27 Sep 2021
Gilead marks fifth approval for Trodelvy in metastatic triple negative breast cancer under Project Orbis initiative with Health Canada authorisation
27 September 2021 - Antibody-drug conjugate Trodelvy is first treatment to show survival benefit versus standard of care in metastatic triple ...
Posted by Michael Wonder on 27 Sep 2021
Canadian cancer patients have new affordable treatment option
27 September 2021 - Apobiologix expanded its leadership in Canada's biosimilar market with the approval of its first therapeutic treatment, Bambevi. ...
Posted by Michael Wonder on 27 Sep 2021
Access to and affordability of cancer medicines: time to focus on the last mile
21 September 2021 - In The Lancet Oncology, Adam Fundytus and colleagues present results from a global survey of oncologists on ...
Posted by Michael Wonder on 27 Sep 2021
Could discount PBS prices become ‘a thing of the past?’
27 September 2021 - The Guild has reportedly “declared war” on discounters like Chemist Warehouse, which says the suggested copay ...
Posted by Michael Wonder on 27 Sep 2021
Will price of Avastin, staple in anti-cancer therapy, go down?
27 September 2021 - Avastin (bevacizumab), a vascular endothelial growth factor (VEGF) inhibitor, is almost a staple in anticancer treatment ...
Posted by Michael Wonder on 27 Sep 2021
U.S. Food and Drug Administration accepts Bristol Myers Squibb’s applications for Opdivo (nivolumab) + Yervoy (ipilimumab) and Opdivo + chemotherapy for unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma
27 September 2021 - Applications based on Phase 3 CheckMate-648 trial, in which both Opdivo-based combinations demonstrated a significant overall survival ...
Posted by Michael Wonder on 27 Sep 2021
CMS will pay for COVID-19 booster shots, eligible consumers can receive at no cost
24 September 2021 - Following the FDA's recent action that authorized a booster dose of the Pfizer COVID-19 vaccine for certain ...
Posted by Michael Wonder on 27 Sep 2021
EMA evaluating data on booster dose of COVID-19 vaccine Spikevax
27 September 2021 - EMA has started evaluating an application for the use of a booster dose of Spikevax (Moderna’s ...
Posted by Michael Wonder on 27 Sep 2021
Japan’s MHLW approves Padcev (enfortumab vedotin) for advanced urothelial cancer
27 September 2021 - Enfortumab vedotin is the first and only antibody-drug conjugate approved in Japan for patients with advanced ...
Posted by Michael Wonder on 26 Sep 2021
On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19
24 September 2021 - The World Health Organization welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, ...
Posted by Michael Wonder on 26 Sep 2021
Australia secures supply of drug that treats arthritis and Covid
25 September 2021 - Health Minister Greg Hunt has secured an extra supply of a rheumatoid arthritis drug to treat critically ...